From assessments of new product adoption such as companion diagnostics and next-generation sequencing to forecasts, financial benchmarking, and a complete view of the global competitive landscape, BBC is the leader in Molecular Diagnostics (Nucleic Acid Testing) market insights. We go behind the numbers, delivering annual, biannual, quarterly and custom reports on clinical diagnostic product activity for more than 25 companies. As testing moves beyond the laboratory, BBC is staying ahead of what’s next for our NAT clients with surveillance of potential Near Patient Testing (NPT)/Point of Care (POC) applications in the decentralized testing setting.
Including viral (HIV, HCV, HBV, and respiratory viral testing) and bacterial (CT/NG, MRSA/SA, C. difficile, MTB, GBS, and vaginitis).
Includes testing of blood products such as whole blood plasma using NAT assays for HIV, HCV, HBV, WNV, HAV, and Parvovirus.
Includes HPV testing for cervical cancer screening and HPV genotyping for patient management. Also includes companion diagnostic testing such as KRAS, BRAF, and EGFR and other oncology assays for prostate cancer (PCA3), CML (BCR-ABL), and other cancers.
Includes tests for cystic fibrosis, transplantation/autoimmune (HLA), coagulation (Factor V/Factor II/MTHFR), and pharmacogenetic testing (e.g. CYP450).
American Association for Blood Banks (AABB)
American Association for Clinical Chemistry (AACC)
American College of Medical Genetics and Genomics (ACMG)
American Society of Clinical Oncology (ASCO)
American Society of Human Genetics (ASHG)
American Society of Microbiology (ASM)
Association for Molecular Pathology (AMP)
Clinical Virology Symposium (CVS)
European Congress of Clinical Microbiology and Infectious Diseases (ESCMID)